本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Iovance Biotherapeutics, Inc.

1.71
-0.0850-4.75%
成交量:1,256.49万
成交额:2,156.95万
市值:5.69亿
市盈率:-1.38
高:1.81
开:1.80
低:1.68
收:1.79
数据加载中...
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]